Mammakarzinom

5 Studien
OlympiA2021Adjuvant Olaparib for High-Risk gBRCA-Mutant Early Breast CancerKEYNOTE-5222020Pembrolizumab + Chemotherapy in Early Triple-Negative Breast CancermonarchE2020Adjuvant Abemaciclib in High-Risk HR+/HER2– Early Breast CancerKATHERINE2019Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast CancerCLEOPATRA2012Clinical Evaluation of Pertuzumab and Trastuzumab